Agilent 3. März 2026 Morgan Stanley Lowers Agilent Technologies (NYSE:A) Price Target to $160.00 - MarketBeat
Agilent 3. März 2026 Morgan Stanley Lowers Price Target on Agilent Technologies to $160 From $180, Keeps Overweight Rating - marketscreener.com
Agilent 3. März 2026 Champlain Investment Partners LLC Has $114.97 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent 3. März 2026 Agilent's Stock Plummets 2.64% as Trading Volume Dips to $0.41B, Ranking 322 in Daily Trading Activity Amid Earnings Miss and Post-Earnings Rally - Bitget
Agilent 2. März 2026 Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent 2. März 2026 Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent 2. März 2026 Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent 2. März 2026 Morgan Stanley cuts Agilent stock price target on valuation multiples - Investing.com
Agilent 2. März 2026 Morgan Stanley cuts Agilent stock price target on valuation multiples - Investing.com
Agilent 2. März 2026 Assessing Agilent Technologies (A) Valuation After Recent Share Price Softness and Long Term Gains - Yahoo Finance
Agilent 2. März 2026 Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 34.15% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Agilent 1. März 2026 Agilent Technologies Inc.: Why This Lab-Tech Giant Is Suddenly on Every Trader’s Radar - AD HOC NEWS
Agilent 1. März 2026 William Blair Investment Management LLC Has $275.19 Million Stake in Agilent Technologies, Inc. $A - MarketBeat
Agilent 1. März 2026 Agilent (A) Gets Lower Goldman Sachs Target Despite Long-Term Growth Confidence - Finviz
Agilent 28. Feb. 2026 Agilent Technologies, Inc. $A Shares Acquired by Findlay Park Partners LLP - MarketBeat
Agilent 28. Feb. 2026 Agilent’s New FDA Approval And What It Could Mean For Investors - simplywall.st